Skip to content

Ligand Pharmaceuticals

US · LGND #1920 by market cap Listed 1970
286.85 -0.09 -0.03%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Quant vs Street three independent views, side by side

StockVane factor grade
B
Momentum strategy signal
Hold
Analyst consensus
Buy

Mostly aligned, one view stands apart.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

Analyst consensus 8 analysts

Buy
Avg price target 367.00 +27.9%
Price target rangecurrent 286.85
Low346.00
Avg367.00
High406.00
Buy 100% Hold 0% Sell 0%
Recent ratings (25)
DateFirmAnalystRatingTarget
2026-11-12 H.C. Wainwright -- Buy 358.00
2026-11-11 Barclays -- Buy 350.00
2026-11-05 Citi -- Buy 402.00
2026-11-01 RBC Capital -- Buy 357.00
2026-10-30 BofA Securities -- Buy 406.00
2026-10-30 Stifel -- Buy 350.00
2026-10-30 Barclays -- Buy 345.00
2026-10-30 Oppenheimer -- Buy 346.00
2026-10-29 Citi -- Buy 397.00
2026-10-29 H.C. Wainwright -- Buy 358.00
2026-10-29 RBC Capital -- Buy 357.00
2026-10-19 BofA Securities -- Buy 406.00
2026-09-25 Barclays -- Buy 345.00
2026-09-24 Craig-Hallum -- Buy --
2026-09-24 H.C. Wainwright -- Buy 358.00
2026-09-23 Citi -- Buy 397.00
2026-09-22 Craig-Hallum -- Buy --
2026-09-22 BofA Securities -- Buy 388.00
2026-09-22 Stifel -- Buy --
2026-09-22 Citi -- Buy 397.00
2026-09-21 H.C. Wainwright -- Buy 358.00
2026-08-14 Stifel -- Buy 332.00
2026-08-12 Citi -- Buy 390.00
2026-08-09 RBC Capital -- Buy 345.00
2026-08-07 Craig-Hallum -- Buy 370.00

Price target trend monthly average, last 3 years

Earnings history price reaction on the day

PeriodReport dateSessionOptions expectedActual move
2026/Q3 2026-10-29 -- ±7.50% -0.45% (in line)
2026/Q2 2026-08-06 -- ±7.03% -0.80% (in line)
2026/Q1 2026-05-07 -- ±6.32% -9.55% (beat)
2025/Q4 2026-02-26 -- ±8.12% +2.50% (in line)
2025/Q3 2025-11-06 -- ±5.73% +9.37% (beat)
2025/Q2 2025-08-07 -- ±7.16% +2.75% (in line)
2025/Q1 2025-05-08 -- ±11.73% -2.94% (in line)
2024/Q4 2025-02-27 -- ±10.17% +0.57% (in line)
2024/Q3 2024-11-07 -- ±9.17% +11.12% (beat)
2024/Q2 2024-08-06 After close ±9.54% -5.78% (in line)
2024/Q1 2024-05-07 After close ±9.58% +9.75% (beat)
2023/Q4 2024-02-27 -- ±8.17% +19.86% (beat)

"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Ligand Pharmaceuticals discussion 0 comments

Add a comment